Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 80%
Prognostiker
15
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 17 Stunden
Veraltet21. Feb. 23, 20:26 UTC31. Dez. 27, 22:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiFDA approves skin cancer vaccine by which date?
PolymarketWill the FDA approve any psychedelic substance for medical use this year?
KalshiRegeln
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of malaria in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Offene Märkte
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will FDA approve any mRNA vaccine against malaria before 2028??
- Manifold Markets bewertet No mit 80% (Stand: 8. September 2026).
- Wann wird Will FDA approve any mRNA vaccine against malaria before 2028? entschieden?
- Will FDA approve any mRNA vaccine against malaria before 2028? soll am 31. Dezember 2027 entschieden werden.
- Wie wird Will FDA approve any mRNA vaccine against malaria before 2028? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of malaria in the United States before January 1, 2028.